Cargando…

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry

BACKGROUND AND AIMS: The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing in Saudi Arabia (SA), but descriptions of the clinical and metabolic characteristics of these patients are limited. The present study aims to fill this gap. METHODS: Demographic, clinical, and laboratory d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alswat, Khalid, Sanai, Faisal M, Al-hamoudi, Waleed, Ismail, Mona, Dahlan, Yaser, AlGhamdi, Hamdan Saleh, Altraif, Ibrahim, Alalwan, Abduljaleel, Babatin, Mohamed M A, Alqahtani, Saleh A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982437/ https://www.ncbi.nlm.nih.gov/pubmed/33762835 http://dx.doi.org/10.2147/DMSO.S300051

Ejemplares similares

Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia
por: Sanai, Faisal M., et al.
Publicado: (2019)

Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia
por: Abaalkhail, Faisal A., et al.
Publicado: (2021)

Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030
por: Alswat, Khalid, et al.
Publicado: (2018)

Saudi Association for the Study of Liver diseases and Transplantation position statement on the hepatology workforce in Saudi Arabia
por: Al-Judaibi, Bandar, et al.
Publicado: (2022)

SASLT Guidelines: Update in Treatment of Hepatitis C Virus Infection
por: Alghamdi, Abdullah S., et al.
Publicado: (2016)

Saudi Association for the Study of Liver Diseases and Transplantation position statement on liver transplantation during the COVID-19 pandemic
por: Al-Judaibi, Bandar, et al.
Publicado: (2020)

Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

SASLT Position Statement on the Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection
por: Alghamdi, Abdullah S., et al.
Publicado: (2015)

Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

HCV genotypes among 1013 Saudi nationals: a multicenter study
por: Al Traif, Ibrahim, et al.
Publicado: (2013)

Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma
por: Alqahtani, Saleh A., et al.
Publicado: (2020)

Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B
por: Sanai, Faisal M., et al.
Publicado: (2017)

Cholestatic liver disease: Practice guidelines from the Saudi Association for the Study of Liver diseases and Transplantation
por: Mawardi, Mohammad, et al.
Publicado: (2021)

Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation
por: Alqahtani, Saleh A., et al.
Publicado: (2020)

SASLT practice guidelines for the management of Hepatitis B virus – An update
por: Abaalkhail, Faisal A., et al.
Publicado: (2021)

Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: a hospital-based study
por: Al-hamoudi, Waleed, et al.
Publicado: (2012)

Epidemiology, Disease Burden, and Treatment Strategies of Chronic Hepatitis C Virus Infections in Saudi Arabia in the New Treatment Paradigm Shift
por: Aljumah, Abdulrahman A., et al.
Publicado: (2016)

Liver abscess presentation and management in Saudi Arabia and the United Kingdom
por: Albenmousa, Ali, et al.
Publicado: (2011)

Lower prevalence of hepatic fibrosis in low viremic hepatitis B patients with fluctuating HBV DNA levels
por: Sanai, Faisal M., et al.
Publicado: (2022)

SASLT Practice Guidelines for the Management of Hepatitis B Virus
por: Abaalkhail, Faisal, et al.
Publicado: (2014)

SASLT Practice Guidelines for the Management of Hepatitis C Virus Infection: Summary of Recommendations
por: Alghamdi, Abdullah S., et al.
Publicado: (2012)

SASLT Practice Guidelines: Management of Hepatitis C Virus Infection
por: Alghamdi, Abdullah S., et al.
Publicado: (2012)

Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease
por: Alsaif, Faisal A., et al.
Publicado: (2020)

Epidemiology of Pancreatic Cancer in Saudi Arabia: A Retrospective Analysis of Pancreatic Cancer Diagnosed in Saudi Arabia Between 2004 and 2015
por: Alghamdi, Ibrahim G, et al.
Publicado: (2021)

Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Bzeizi, Khalid I., et al.
Publicado: (2021)

Correlation Between Hepatitis B Surface Antigen Titers and HBV DNA Levels
por: Alghamdi, Amal, et al.
Publicado: (2013)

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
por: Broering, Dieter, et al.
Publicado: (2021)

The future health and economic burden of obesity-attributable type 2 diabetes and liver disease among the working-age population in Saudi Arabia
por: Coker, Timothy, et al.
Publicado: (2022)

Diabetes mellitus is not associated with worse short term outcome in patients older than 65 years old post-liver transplantation
por: Alghamdi, Saad, et al.
Publicado: (2023)

Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients
por: Al-Qahtani, Ahmed A., et al.
Publicado: (2017)

Position statement on the diagnosis and management of non-alcoholic fatty liver disease
por: Alswat, Khalid A., et al.
Publicado: (2019)

Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait
por: Sanai, Faisal M., et al.
Publicado: (2021)

The Correlation Between Hepatitis B Virus Precore/Core Mutations and the Progression of Severe Liver Disease
por: Al-Qahtani, Ahmed A., et al.
Publicado: (2018)

Association between IL-37 gene polymorphisms and risk of HBV-related liver disease in a Saudi Arabian population
por: Al-Anazi, Mashael R., et al.
Publicado: (2019)

Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk
por: Al-hamoudi, Waleed, et al.
Publicado: (2020)

Validation of the EVendo score for the prediction of varices in cirrhotic patients
por: Alswat, Khalid, et al.
Publicado: (2022)

Clinical Characteristics of Patients with Hepatocellular Carcinoma in a Middle Eastern Population
por: Alswat, Khalid A., et al.
Publicado: (2013)

Colorectal Cancer Liver Metastasis Trends in the Kingdom of Saudi Arabia
por: Hassanain, Mazen, et al.
Publicado: (2016)

Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions
por: Aljumah, Abdulrahman A., et al.
Publicado: (2019)

Assessing the Severity of Illness in Patients With Coronavirus Disease in Saudi Arabia: A Retrospective Descriptive Cross-Sectional Study
por: Alqahtani, Abdulhadi M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o4v25hpnh7jlrctbo8rske8o24